Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The use of paracetamol during pregnancy: A qualitative study and possible strategies for a clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic yield, complications, pathology and anatomical features in CT-guided percutaneous needle biopsy of mediastinal tumours

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Experiences from COVID-19-driven use of telephone consultations in a cardiology clinic-The CoviTel study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Feeding tube practices and the colonisation of the preterm stomach in the first week of life

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Paracetamol (N-acetyl-p-aminophenol (APAP), also known as acetaminophen) is used to relieve mild to moderate pain and reduce fever. APAP is widely used during pregnancy as it is considered safe when used as directed by regulatory authorities. However, a significant amount of epidemiological and experimental research suggests that prenatal exposure potentially alters fetal development. In this paper, we summarize the potentially harmful adverse effects of APAP and the limitations of the current evidence. It highlights the urgent need for a clinical trial, and the aim of the presented qualitative pilot study on APAP use during pregnancy is the feasibility of a large-scale randomized controlled trial (RCT). In the qualitative study, we included 232 Danish women from three hospitals in the spring of 2021. After recognizing the pregnancy, 48% had taken any APAP, and 6% had taken it weekly or more than weekly. A total of 27% who had taken APAP in the first trimester of pregnancy (even rarely) would potentially participate in an RCT. In a potential clinical trial, the women would need to be included early in the 1st trimester as the suspected harmful effects of APAP lies within this early reproductive developmental window. A possible recruitment strategy was explored. These data suggest that the target population appears positive towards an RCT. As a negative attitude among users has been considered the major hindrance for such a study, we cannot see hindrances for performing an RCT.

Original languageEnglish
Article numbere0271537
JournalPLoS One
Volume17
Issue number9
Pages (from-to)e0271537
ISSN1932-6203
DOIs
Publication statusPublished - 2022

    Research areas

  • Acetaminophen/adverse effects, Female, Fetal Development, Humans, Pregnancy, Pregnancy Trimester, First, Qualitative Research

ID: 84679538